Page last updated: 2024-11-07

spironolactone and Lipidoses

spironolactone has been researched along with Lipidoses in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, A1
Seki, K1
Kitani, T1
Matsuzawa, Y1
Adachi, S1

Reviews

1 review available for spironolactone and Lipidoses

ArticleYear
[Drug-induced lipidosis: formation of myeloid bodies (author's transl)].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1974, Volume: 19, Issue:4

    Topics: Animals; Diethylamines; Ethanolamines; Gangliosides; Haplorhini; Hexestrol; Humans; Inclusion Bodies

1974